.jpg)




JunPyo Han , Yujin Jang
, Dong Yeop Shin
et al.
J Cancer Prev 2022; 27(4): 199-207
https://doi.org/10.15430/JCP.2022.27.4.199Nur Mahirah Amani Binti Mohammad , Mohd Razif Shahril
, Suzana Shahar
et al.
J Cancer Prev 2022; 27(4): 208-220
https://doi.org/10.15430/JCP.2022.27.4.208Soojung Jin , Jung-ha Park
, Hee Jung Yun
et al.
J Cancer Prev 2022; 27(4): 221-228
https://doi.org/10.15430/JCP.2022.27.4.221Eun-Ryeong Hahm , Sivapar V. Mathan
, Rana P. Singh
et al.
J Cancer Prev 2022; 27(2): 101-111
https://doi.org/10.15430/JCP.2022.27.2.101Emmanuelle Laguerre , Tracy Matthews
J Cancer Prev 2022; 27(2): 79-88
https://doi.org/10.15430/JCP.2022.27.2.79Athena Dong , Xiaoqing Pan
, Chien-Wei Lin
et al.
J Cancer Prev 2022; 27(2): 129-138
https://doi.org/10.15430/JCP.2022.27.2.129Emmanuelle Laguerre , Tracy Matthews
J Cancer Prev 2022; 27(2): 79-88
https://doi.org/10.15430/JCP.2022.27.2.79Athena Dong , Xiaoqing Pan
, Chien-Wei Lin
et al.
J Cancer Prev 2022; 27(2): 129-138
https://doi.org/10.15430/JCP.2022.27.2.129Eun-Ryeong Hahm , Sivapar V. Mathan
, Rana P. Singh
et al.
J Cancer Prev 2022; 27(2): 101-111
https://doi.org/10.15430/JCP.2022.27.2.101The aim of the journal is to promote an increased awareness of all aspects that ultimately lead to cancer prevention. The journal publishes important original research articles, reviews, editorials, short communications, and letters to the editor with the multi-disciplinary perspectives in the areas of carcinogenesis, chemoprevention, molecular epidemiology, and cancer biology. The journal comprises basic, clinical, and translational research with special attention given to molecular and cellular mechanisms of cancer chemopreventive agents as well as identification of novel risk factors and biomarkers of cancer.
+82-2-888-9122